Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00941915 · ClinicalTrials.gov registry record · NA

Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer

A NA study of Prostate Cancer, sponsored by Duke University.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT00941915 is a NA study of Prostate Cancer that has completed, run by Duke University. The registered enrollment target is 60 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00941915, a NA study of Prostate Cancer, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the incidence of urinary and gastrointestinal acute and late side effects in patients treated with stereotactic body radiotherapy (SBRT) to the prostate. Stereotactic radiation therapy is given as five treatments over a 2-3 week period. The prostate is localized and the plan is reoptimized as needed prior to each treatment.

Conditions Studied

Prostate Cancer

Interventions

  • RADIATION SBRT Prostate

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2009-11-09
Est. Completion 2020-07-17
Phase NA

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00941915

The ClinicalTrials.gov registry entry for NCT00941915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which SBRT Prostate is the first listed.

NCT00941915 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00941915 about?

NCT00941915 is a clinical study titled "Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer". The purpose of this study is to evaluate the incidence of urinary and gastrointestinal acute and late side effects in patients treated with stereotactic body radiotherapy (SBRT) to the prostate. Stereotactic radiation therapy is given as five treatments over a 2-3 week period. The prostate is locali...

What is the current status of trial NCT00941915?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2009-11-09. Estimated completion is 2020-07-17.

What conditions does trial NCT00941915 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT00941915?

The interventions under investigation include: SBRT Prostate (RADIATION).

Who is sponsoring clinical trial NCT00941915?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00941915 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.